Overview
icometrix was founded as a spin-off from KU Leuven and imec, developing AI software that automatically analyzes brain MRI scans to quantify structures and detect biomarkers relevant to neurological conditions. The platform was used in clinical trials and routine care for diseases including multiple sclerosis, Alzheimer's disease, and stroke.
The company's technology helps radiologists and neurologists extract structured, quantitative data from MRI scans that would otherwise require significant manual effort. Its algorithms were validated in academic and clinical settings and received CE marking and FDA clearance for clinical use.
GE HealthCare acquired icometrix in September 2025, integrating the brain AI analytics software into GE HealthCare's global imaging portfolio. The acquisition provides icometrix with distribution through GE HealthCare's installed base of MRI scanners worldwide.
Funding & milestones
3 events found for icometrix · 2019–2025
Venture roundVenture / equity1 source$18M
Reported amount $18,000,000
Company-issued release confirms USD 18m new financing.
Funding eventType unspecifiedDetailsAmount not disclosed
Source not attached to this recordDeal recordAcquisition2 sourcesAmount not disclosed
Acquirer announces signed agreement to buy icometrix; financial terms were undisclosed at announcement. Acquisition is not capital raised by the company.
ParticipantsGE HealthCare
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- Acquisition by GE HealthCare (September 2025). See icometrix Acquisition 2025.
Key people
In the news
- Neurological imaging demands precision, especially when findings need to be interpreted consistently across readers and over time. In practice, differences in reporting approaches and manual comparison steps can lead to variability in how lesion burden and longitudinal change are described. icobrain, developed by icometrix and now part of GE HealthCare, automatically analyzes #brain scans and helps: ☑️ structure how findings are assessed and reported, delivering objective, quantitative results directly within the reporting
- Neurological imaging demands precision, especially when findings need to be interpreted consistently across readers and over time. In practice, differences in reporting approaches and manual comparison steps can lead to variability in how lesion burden and longitudinal change are described. icobrain, developed by icometrix and now part of GE HealthCare, automatically analyzes #brain scans and helps: ☑️ structure how findings are assessed and reported, delivering objective, quantitative results directly within the reporting
- Attending #MSToronto? #MRI follow-up is central to #MS care but comparing scans over time can still depend heavily on manual assessment, reporting habits, and how findings are documented. At #MSToronto2026, 21–23 October, we’ll be showing how icobrain ms brings quantitative lesion and brain volume measurements into a structured reporting workflow, helping make longitudinal changes easier to track and communicate. Rebecca Bartz, Vincenzo Anania, and Nuno Miguel Pedrosa de Barros will be at booth 430 to discuss how quantitative #MRI
- Attending #MSToronto? #MRI follow-up is central to #MS care but comparing scans over time can still depend heavily on manual assessment, reporting habits, and how findings are documented. At #MSToronto2026, 21–23 October, we’ll be showing how icobrain ms brings quantitative lesion and brain volume measurements into a structured reporting workflow, helping make longitudinal changes easier to track and communicate. Rebecca Bartz, Vincenzo Anania, and Nuno Miguel Pedrosa de Barros will be at booth 430 to discuss how quantitative #MRI
- Attending #SENRS in Nashville? From 12–18 October, spine imaging experts will come together to share clinical experience, research, and new approaches to some of the most complex challenges in #neuroradiology. At icometrix, we’re looking forward to exploring how quantitative imaging and structured reporting can support longitudinal assessment, turning imaging data into information that remains consistent and useful over time. Vanessa L. Siliezar will be at #SENRS26 to connect with colleagues and discuss where quantitative
- Attending #ASFNR26 in Newport Beach? From 10–12 October, the meeting brings together experts shaping the future of #neuroimaging, from new research and quantitative imaging to its role in clinical practice. At icometrix, we’re particularly interested in the conversation around turning quantitative imaging into structured, clinically useful information. Dirk Smeets and Vanessa L. Siliezar will be at #ASFNR to connect with colleagues, share perspectives, and discuss how quantitative #neuroimaging can become part of everyday reporting,
- See you at #JFR in Paris 🇫🇷 From 8–11 October, #radiologists from across the field will gather in Paris to exchange ideas on the future of #imaging and clinical practice. At icometrix, we’ll be there to discuss a more structured approach to #neuroimaging, one that turns quantitative #MRI insights into standardized information within the reporting workflow. Jan Verheyden will be at the GE HealthCare booth 102B, to share how #icobrain supports reporting across conditions such as #MS, #dementia and #ARIA monitoring. If you’re at
- Heading to #NeuroRad in Mainz? 🇩🇪 From 7–9 October, the icometrix team will be at #NeuroRad26, meeting with #radiologists and #neurologists to discuss how quantitative neuroimaging can support more structured, consistent reporting. Jaime Simarro Viana, PhD and Mona Irsfeld will be joining the GE HealthCare booth #5, where you can explore how #icobrain brings clinically validated #AI directly into the reporting workflow, from automated prior identification and lesion comparison to quantitative brain volume analysis. If
Alumni 1 went on to found or lead
David RobbenSenior Researcher→Co-Founder at Legidex
Dirk LoeckxCo-Founder & board member→Board Member at Biovia
Backers
Capricorn Partners
Leuven-based VC with EUR 300M+ AUM, investing in cleantech, digital, health, and fusion technology with over 30 years of experience.
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.